Marriott International, Inc. (NASDAQ: MAR) on Tuesday announced financial results for the fourth quarter of 2024, reporting a decrease in adjusted earnings despite a modest increase in revenue.
- Total revenue increased 5% year-over-year to $6.43 billion in the fourth quarter, reflecting growth across all operating segments
- In the fourth quarter, worldwide Revenue Per Available Room rose 5%, driven by gains in both ADR and occupancy
- On a reported basis, Q4 earnings decreased to $1.63 per share from $2.87 per share in the prior-year quarter
- Net income totaled $455 million in Q4, compared to $848 million a year earlier
- Adjusted earnings dropped to $2.45 per share from $3.57 per share
- Operating income increased to $752 million in the December quarter from $718 million in the prior-year period
- Adjusted EBITDA was $1.29 billion in the fourth quarter, which is up 7% from $1.20 billion reported in Q4 2023
- For the first quarter, the management expects worldwide comparable systemwide constant RevPAR growth to be 3-4%
- In the full fiscal year, worldwide comparable systemwide constant RevPAR growth is expected to be 2-4%
The post Earnings Summary: Highlights of Marriott International’s Q4 2024 results first appeared on AlphaStreet.
Marriott International, Inc. (NASDAQ: MAR) on Tuesday announced financial results for the fourth quarter of 2024, reporting a decrease in adjusted earnings despite a modest increase in revenue. Total revenue
The post Earnings Summary: Highlights of Marriott International’s Q4 2024 results first appeared on AlphaStreet.
Marriott International, Inc. (NASDAQ: MAR) on Tuesday announced financial results for the fourth quarter of 2024, reporting a decrease in adjusted earnings despite a modest increase in revenue.
- Total revenue increased 5% year-over-year to $6.43 billion in the fourth quarter, reflecting growth across all operating segments
- In the fourth quarter, worldwide Revenue Per Available Room rose 5%, driven by gains in both ADR and occupancy
- On a reported basis, Q4 earnings decreased to $1.63 per share from $2.87 per share in the prior-year quarter
- Net income totaled $455 million in Q4, compared to $848 million a year earlier
- Adjusted earnings dropped to $2.45 per share from $3.57 per share
- Operating income increased to $752 million in the December quarter from $718 million in the prior-year period
- Adjusted EBITDA was $1.29 billion in the fourth quarter, which is up 7% from $1.20 billion reported in Q4 2023
- For the first quarter, the management expects worldwide comparable systemwide constant RevPAR growth to be 3-4%
- In the full fiscal year, worldwide comparable systemwide constant RevPAR growth is expected to be 2-4%
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion. Net income attributable to Biogen Inc. was $266.8 million,
Important takeaways from Coca-Cola’s (KO) Q4 2024 earnings
The Coca-Cola Company (NYSE: KO) has wrapped up fiscal 2024 on an upbeat note, reporting stronger-than-expected results for the final quarter of the year. Encouraged by the growth in sales
Walt Disney (DIS): A look at the performance of the streaming business in 1Q25
Shares of The Walt Disney Company (NYSE: DIS) dropped 1% on Tuesday. The stock has gained 6% over the past three months. The company delivered top and bottom line growth
Tags